Literature DB >> 8083346

Molecular cloning of hamster brain and atrial natriuretic peptide cDNAs. Cardiomyopathic hamsters are useful models for brain and atrial natriuretic peptides.

N Tamura1, Y Ogawa, H Itoh, H Arai, S Suga, O Nakagawa, Y Komatsu, I Kishimoto, K Takaya, T Yoshimasa.   

Abstract

Brain and atrial natriuretic peptides (BNP and ANP) are cardiac hormones with diuretic, natriuretic, and vasodilatory activities. Cardiomyopathic hamsters are widely used animal models of heart failure. Due to the structural divergence of BNP among species, examination on pathophysiological roles of BNP using cardiomyopathic hamsters is so far impossible. We therefore isolated hamster BNP and ANP cDNAs, and investigated synthesis and secretion of these peptides in normal and cardiomyopathic hamsters. The COOH-terminal 32-residue peptide of cloned hamster preproBNP with 122 amino acids, preceded by a single arginine residue, supposedly represents hamster BNP showing < 50% homology to rat BNP. Alpha-hamster ANP, 28-residue peptide, is identical to alpha-rat ANP. In hamsters, BNP and ANP occur mainly in the ventricle and the atrium, respectively. The 32-wk-old hypertrophic cardiomyopathic BIO14.6 strain exhibited ventricular hypertrophy. The 32-wk-old dilated cardiomyopathic BIO53.58 strain remained at the stage without apparent heart failure. In BIO14.6 and BIO53.58 strains at this age, ventricular BNP and ANP gene expressions are augmented, and the plasma BNP concentration is elevated to 136 and 108 fmol/ml, respectively, three times greater than the elevated plasma ANP concentration, which well mimics changes of the plasma BNP and ANP concentrations in human heart failure. Cardiomyopathic hamsters, therefore, are useful models to investigate the implication of BNP in human cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083346      PMCID: PMC295163          DOI: 10.1172/JCI117420

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

Review 1.  Transcription termination and 3' processing: the end is in site!

Authors:  M L Birnstiel; M Busslinger; K Strub
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

2.  Rat brain natriuretic peptide--tissue distribution and molecular form.

Authors:  Y Ogawa; K Nakao; M Mukoyama; G Shirakami; H Itoh; K Hosoda; Y Saito; H Arai; S Suga; M Jougasaki
Journal:  Endocrinology       Date:  1990-04       Impact factor: 4.736

Review 3.  Myopathy of hamster dystrophy: history and morphologic aspects.

Authors:  F Homburger
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

Review 4.  Hereditary cardiomyopathy: a new disease model.

Authors:  E Bajusz
Journal:  Am Heart J       Date:  1969-05       Impact factor: 4.749

5.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

Authors:  M Mukoyama; K Nakao; K Hosoda; S Suga; Y Saito; Y Ogawa; G Shirakami; M Jougasaki; K Obata; H Yasue
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

6.  Natriuretic peptide system in human heart failure.

Authors:  C M Wei; D M Heublein; M A Perrella; A Lerman; R J Rodeheffer; C G McGregor; W D Edwards; H V Schaff; J C Burnett
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

7.  Alpha-human atrial natriuretic polypeptide is released from the heart and circulates in the body.

Authors:  A Sugawara; K Nakao; N Morii; M Sakamoto; M Suda; M Shimokura; Y Kiso; M Kihara; Y Yamori; K Nishimura
Journal:  Biochem Biophys Res Commun       Date:  1985-06-14       Impact factor: 3.575

8.  Radioimmunoassay for alpha-human and rat atrial natriuretic polypeptide.

Authors:  K Nakao; A Sugawara; N Morii; M Sakamoto; M Suda; J Soneda; T Ban; M Kihara; Y Yamori; M Shimokura
Journal:  Biochem Biophys Res Commun       Date:  1984-11-14       Impact factor: 3.575

9.  Ventricles as a major site of atrial natriuretic factor synthesis and release in cardiomyopathic hamsters with heart failure.

Authors:  G Thibault; M Nemer; J Drouin; J P Lavigne; J Ding; C Charbonneau; R Garcia; J Genest; G Jasmin; M Sole
Journal:  Circ Res       Date:  1989-07       Impact factor: 17.367

10.  Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide.

Authors:  T Sudoh; K Maekawa; M Kojima; N Minamino; K Kangawa; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1989-03-31       Impact factor: 3.575

View more
  6 in total

1.  Temperature has a major influence on cardiac natriuretic peptide in salmon.

Authors:  V Tervonen; K Kokkonen; H Vierimaa; H Ruskoaho; O Vuolteenaho
Journal:  J Physiol       Date:  2001-10-01       Impact factor: 5.182

2.  The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes.

Authors:  K Kuwahara; Y Saito; E Ogawa; N Takahashi; Y Nakagawa; Y Naruse; M Harada; I Hamanaka; T Izumi; Y Miyamoto; I Kishimoto; R Kawakami; M Nakanishi; N Mori; K Nakao
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  Cardiac fibrosis in mice lacking brain natriuretic peptide.

Authors:  N Tamura; Y Ogawa; H Chusho; K Nakamura; K Nakao; M Suda; M Kasahara; R Hashimoto; G Katsuura; M Mukoyama; H Itoh; Y Saito; I Tanaka; H Otani; M Katsuki
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

4.  Characterization of the 5'-flanking region and chromosomal assignment of the human brain natriuretic peptide gene.

Authors:  Y Ogawa; H Itoh; O Nakagawa; G Shirakami; N Tamura; T Yoshimasa; K Nagata; N Yoshida; K Nakao
Journal:  J Mol Med (Berl)       Date:  1995-09       Impact factor: 4.599

5.  Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.

Authors:  O Nakagawa; Y Ogawa; H Itoh; S Suga; Y Komatsu; I Kishimoto; K Nishino; T Yoshimasa; K Nakao
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

6.  Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats.

Authors:  Y Ogawa; H Masuzaki; N Isse; T Okazaki; K Mori; M Shigemoto; N Satoh; N Tamura; K Hosoda; Y Yoshimasa
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.